Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onasis Holdings Corp is a diversified holding company that operates primarily within the healthcare and wellness industries. The company's core focus is on the development and commercialization of over-the-counter (OTC) medical products, most notably through its subsidiary brand, Elixicure. Elixicure produces a line of natural, CBD-infused topical pain relief creams designed as non-addictive alternatives to traditional analgesics. Beyond consumer wellness, Onasis has historically engaged in the distribution of medical supplies and personal protective equipment. The company seeks to identify and acquire undervalued assets in the life sciences and healthcare space to drive long-term growth. Its products are particularly targeted toward athletes and individuals seeking plant-based pain management solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ONASIS Holdings.